Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Febbraio

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
American Journal of Physiology. Renal Physiology|July 14, 2012
CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathiesRichard J Baines, Ravinder S Chana, Matthew Hall, et al.
The Journal of Clinical Investigation|October 28, 2010
CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCsWei Li, Maria Febbraio, Sekhar P Reddy, et al.
Frontiers in Cardiovascular Medicine|December 10, 2021
Endothelial Cell CD36 Reduces Atherosclerosis and Controls Systemic MetabolismUmar R Rekhi, Mohamed Omar, Maria Alexiou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injuryEunhee Kim, Aaron T Tolhurst, Lu Ye Qin, et al.
Infection and Immunity|December 24, 2002
CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparumTodd G Smith, Lena Serghides, Samir N Patel, et al.
Cardiovascular Research|November 20, 2010
A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signallingDavid J Kennedy, Sai Kuchibhotla, Kristen M Westfall, et al.
The Journal of Clinical Investigation|November 9, 2005
CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretionsFabienne Laugerette, Patricia Passilly-Degrace, Bruno Patris, et al.
The American Journal of Pathology|June 21, 2015
The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injurySubramaniam Pennathur, Katie Pasichnyk, Nadia M Bahrami, et al.
Cardiovascular Research|December 11, 2007
Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/IISai Kuchibhotla, Difernando Vanegas, David J Kennedy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Ribosomal protein L13a deficiency in macrophages promotes atherosclerosis by limiting translation control-dependent retardation of inflammationAbhijit Basu, Darshana Poddar, Peggy Robinet, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
American Journal of Physiology. Renal Physiology|July 14, 2012
CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathiesRichard J Baines, Ravinder S Chana, Matthew Hall, et al.
The Journal of Clinical Investigation|October 28, 2010
CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCsWei Li, Maria Febbraio, Sekhar P Reddy, et al.
Frontiers in Cardiovascular Medicine|December 10, 2021
Endothelial Cell CD36 Reduces Atherosclerosis and Controls Systemic MetabolismUmar R Rekhi, Mohamed Omar, Maria Alexiou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injuryEunhee Kim, Aaron T Tolhurst, Lu Ye Qin, et al.
Infection and Immunity|December 24, 2002
CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparumTodd G Smith, Lena Serghides, Samir N Patel, et al.
Cardiovascular Research|November 20, 2010
A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signallingDavid J Kennedy, Sai Kuchibhotla, Kristen M Westfall, et al.
The Journal of Clinical Investigation|November 9, 2005
CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretionsFabienne Laugerette, Patricia Passilly-Degrace, Bruno Patris, et al.
The American Journal of Pathology|June 21, 2015
The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injurySubramaniam Pennathur, Katie Pasichnyk, Nadia M Bahrami, et al.
Cardiovascular Research|December 11, 2007
Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/IISai Kuchibhotla, Difernando Vanegas, David J Kennedy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Ribosomal protein L13a deficiency in macrophages promotes atherosclerosis by limiting translation control-dependent retardation of inflammationAbhijit Basu, Darshana Poddar, Peggy Robinet, et al.
Pageof 15